Two Sigma Investments’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.95M Sell
940,582
-112,399
-11% -$233K ﹤0.01% 1814
2025
Q1
$2.32M Buy
1,052,981
+62,812
+6% +$138K 0.01% 1600
2024
Q4
$1.51M Sell
990,169
-411,906
-29% -$630K ﹤0.01% 1849
2024
Q3
$2.79M Buy
1,402,075
+295,639
+27% +$588K 0.01% 1410
2024
Q2
$3.87M Buy
1,106,436
+1,025,872
+1,273% +$3.59M 0.01% 1071
2024
Q1
$223K Buy
+80,564
New +$223K ﹤0.01% 2600
2023
Q3
Sell
-36,500
Closed -$42.3K 2984
2023
Q2
$42.3K Sell
36,500
-112,000
-75% -$130K ﹤0.01% 2764
2023
Q1
$224K Sell
148,500
-124,581
-46% -$188K ﹤0.01% 2444
2022
Q4
$683K Buy
273,081
+120,863
+79% +$302K ﹤0.01% 1829
2022
Q3
$642K Buy
152,218
+45,163
+42% +$190K ﹤0.01% 1613
2022
Q2
$299K Buy
+107,055
New +$299K ﹤0.01% 1963
2020
Q2
Sell
-116,226
Closed -$1.36M 2154
2020
Q1
$1.36M Sell
116,226
-17,757
-13% -$208K 0.01% 830
2019
Q4
$3.15M Buy
+133,983
New +$3.15M 0.01% 915
2018
Q3
Sell
-8,780
Closed -$341K 2156
2018
Q2
$341K Buy
+8,780
New +$341K ﹤0.01% 1750